Premier Biomedical (OTCMKTS:BIEI) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?
by Scott Moore · The Cerbat GemPremier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0008. Premier Biomedical shares last traded at $0.0008, with a volume of 3,609,451 shares trading hands.
Premier Biomedical Stock Up 14.3%
Premier Biomedical Company Profile
Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.
See Also
- Five stocks we like better than Premier Biomedical
- Financials Hit Record Highs as the AI Trade Unravels—Can They Keep Leading?
- Netflix’s Big Sell-Off May Be Sending the Wrong Signal
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus